0001724521-23-000008.txt : 20230920
0001724521-23-000008.hdr.sgml : 20230920
20230920164746
ACCESSION NUMBER: 0001724521-23-000008
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230918
FILED AS OF DATE: 20230920
DATE AS OF CHANGE: 20230920
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nuyten Dimitry SA
CENTRAL INDEX KEY: 0001776564
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38419
FILM NUMBER: 231266976
MAIL ADDRESS:
STREET 1: 740 HEINZ AVENUE
STREET 2: C/O ADURO BIOTECH, INC.
CITY: BERKELEY
STATE: CA
ZIP: 94710
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arcus Biosciences, Inc.
CENTRAL INDEX KEY: 0001724521
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473898435
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3928 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: (510) 694-6200
MAIL ADDRESS:
STREET 1: 3928 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
4
1
wk-form4_1695242857.xml
FORM 4
X0508
4
2023-09-18
0
0001724521
Arcus Biosciences, Inc.
RCUS
0001776564
Nuyten Dimitry SA
C/O ARCUS BIOSCIENCES, INC.
3928 POINT EDEN WAY
HAYWARD
CA
94545
0
1
0
0
Chief Medical Officer
1
Common Stock
2023-09-18
4
D
0
3708
20.40
D
73591
D
Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on January 15, 2021, and does not represent a discretionary trade by the reporting person.
Includes 799 shares purchased on 5/31/2023 through the Company's Employee Stock Purchase Plan.
/s/ Carolyn Tang, Attorney-in-Fact
2023-09-20